Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. ADR (NQ: SNY )

50.21 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 267
Open 50.21
Bid (Size) 49.03 (12)
Ask (Size) 49.06 (10)
Prev. Close 50.21
Today's Range 50.21 - 50.21
52wk Range 42.63 - 55.72
Shares Outstanding 1,250,690,553
Dividend Yield 3.79%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Meme Stocks That Are Likely to Crater in 2024
These are the meme stocks to avoid as they represent fundamentally weak companies with a sluggish growth outlook. 
Via InvestorPlace
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector
Pfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D capabilities and job creation. 
Via Benzinga

Performance

YTD
+0.42%
+0.42%
1 Month
+8.59%
+8.59%
3 Month
+8.35%
+8.35%
6 Month
+10.30%
+10.30%
1 Year
-7.94%
-7.94%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024
From Fulcrum Therapeutics, Inc.
Via GlobeNewswire
Why Novavax Stock More Than Doubled Today
Via The Motley Fool
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy
From Fulcrum Therapeutics, Inc.
Via GlobeNewswire
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
Via InvestorPlace
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
Via InvestorPlace
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Via Investor's Business Daily
Exposures COVID-19
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
Via Benzinga
Exposures COVID-19
Why Is Novavax (NVAX) Stock Up 118% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
3 Biotech Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Via InvestorPlace
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Via The Motley Fool
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation
Via Benzinga
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Via The Motley Fool
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024
From Pinnacle Group International
Via ACN Newswire
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Via Talk Markets
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Via Benzinga
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.